316 results
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Oncology product summary 11 Opdivo: U.S. impacted by inventory work down & timing of customer orders vs PY; continued demand growth across indications
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the “Insurance … Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii
424B2
n8pbwm1 lye
13 Feb 24
Prospectus for primary offering
8:00am
424B5
dgh8nr06efvebyod7
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
7cjt0xgg2od2n86czvuq
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.2
zrydmcb578 cb
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am